Dynamic Monitoring of Antibody Drug Conjugates Targeting TROP2 or HER2 in Breast Cancer using Circulating Tumor Cells
Avanish Mishra(Harvard University), Rachel O. Abelman(Massachusetts General Hospital), David T. Ting(Massachusetts General Hospital), Katherine Xu(Center for Cancer Research), Aditya Bardia(UCLA Health), Daniel A. Haber(Howard Hughes Medical Institute), Linda T. Nieman(Massachusetts General Hospital), Justin Kelly(Center for Cancer Research), Leif W. Ellisen(Harvard University), Jon F.(Massachusetts General Hospital), Charles S. Dai(Harvard University), Kaustav A. Gopinathan(Massachusetts General Hospital), Shyamala Maheswaran(Massachusetts General Hospital), Kruthika Kikkeri(Massachusetts General Hospital), Mehmet Toner(Center for Cancer Research), Shih‐Bo Huang(The University of Texas at San Antonio Health Science Center), Victor R. Putaturo(Massachusetts General Hospital), Quinn E. Cunneely(Massachusetts General Hospital), John R. Walsh(Massachusetts General Hospital), Akansha Deshpande(Massachusetts General Hospital), Elizabeth M. Seider(Center for Cancer Research)
Cited by 3